Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Ranolazine MeSH Descriptor Data 2025


MeSH Heading
Ranolazine
Tree Number(s)
D02.065.199.092.850
D02.092.146.113.092.850
D03.383.606.841
Unique ID
D000069458
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000069458
Scope Note
An acetanilide and piperazine derivative that functions as a SODIUM CHANNEL BLOCKER and prevents the release of enzymes during MYOCARDIAL ISCHEMIA. It is used in the treatment of ANGINA PECTORIS.
Entry Term(s)
N-(2,6-dimethylphenyl)-4-(2-hydroxy-3-(2-methoxyphenoxy)propyl)-1-piperazineacetamide
RS 43285
RS 43285-193
RS-43285
Ranexa
Ranolazine Dihydrochloride
Ranolazine HCl
Ranolazine Hydrochloride
Renolazine
Pharm Action
Cardiovascular Agents
Sodium Channel Blockers
Registry Numbers
A6IEZ5M406
0
F71253DJUN
Related Numbers
110445-25-5
95635-55-5
F71253DJUN
Public MeSH Note
2016; RANOLAZINE was indexed under ACETANILIDES and PIPERAZINES 1988-2015
History Note
2016 (1988)
Date Established
2016/01/01
Date of Entry
2015/07/01
Revision Date
2016/04/26
Ranolazine Preferred
RS 43285 Narrower
RS 43285-193 Narrower
Ranexa Narrower
Ranolazine Hydrochloride Narrower
page delivered in 0.162s